Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has earned an average recommendation of “Buy” from the seven analysts that are currently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have issued ratings on the stock in […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Sees Large Growth in Short Interest wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Bank Julius Baer & Co. Ltd Zurich decreased its stake in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 18.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 47,232 shares of the biotechnology company’s stock after selling 11,028 shares during […]